Cargando…
Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications
BACKGROUND: Diabetes complications are the leading cause of mortality in diabetic patients. The common complications are decline in antioxidant capacity and the onset of micro-inflammation syndrome. At present, glucose-responsive nanoparticles are widely used, as they can release insulin-loaded ultr...
Autores principales: | Zhao, Xi, Shi, Anhua, Ma, Qiong, Yan, Xueyan, Bian, Ligong, Zhang, Pengyue, Wu, Junzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237509/ https://www.ncbi.nlm.nih.gov/pubmed/34176494 http://dx.doi.org/10.1186/s12951-021-00928-y |
Ejemplares similares
-
Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy
por: Ma, Qiong, et al.
Publicado: (2021) -
Bioresponsive Functional Phenylboronic Acid-Based Delivery System as an Emerging Platform for Diabetic Therapy
por: Ma, Qiong, et al.
Publicado: (2021) -
In vitro and in vivo evaluation of pterostilbene for the management of diabetic complications
por: Dodda, Dilip, et al.
Publicado: (2020) -
Amorphous Pterostilbene Delivery Systems Preparation—Innovative Approach to Preparation Optimization
por: Rosiak, Natalia, et al.
Publicado: (2023) -
Pterostilbene in Cancer Therapy
por: Obrador, Elena, et al.
Publicado: (2021)